Mar 10
Celularity secures strategic license deal worth up to $35M for biomaterials portfolio
Synthesized from 1 source
Sources (1)
Bias Scale:
LeftCenterRight
Seeking AlphaMar 10, 2026, 12:45 PM
Celularity secures strategic license deal worth up to $35M for biomaterials portfolio60Trust
Comments
No comments yet. Be the first!